Microtransplantation improves the outcome of older patients with newly diagnosed acute myeloid leukemia: a single-center study with long-term follow-up
MST is an effective and tolerable treatment for older AML patients, particularly those aged 60-70 years and those receiving more than three treatment courses. These results support MST as a viable alternative for older patients ineligible for intensive transplantation.
Authors
- Panpan Lv (ORCID: https://orcid.org/0000-0002-7172-7659)
- Tian Tian (ORCID: https://orcid.org/0000-0001-9204-5991)
- Xiao-Shuang Li (ORCID: https://orcid.org/0000-0002-4707-7676)
- Wan-Jun Sun
- Yakun Yang
- Juan Liu (ORCID: https://orcid.org/0000-0002-5515-5611)
- Xiao-mei Huang
- Yan-yan Zhu
Institutions
- Beijing Jiaotong University (CN)
- PLA Army Engineering University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2026-02-27
- DOI
- https://doi.org/10.3389/fonc.2026.1736302
- Primary Topic
- Hematopoietic Stem Cell Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Capital Health Research and Development of Special Fund